ArticleCancer gene therapy2024

PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions.

Yi-Ru Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.